Outcomes of Gatekeeper(TM) prosthesis implantation for the treatment of fecal incontinence: a multicenter observational study


Por: Trenti L, Biondo S, Noguerales F, Nomdedeu J, Coret A, Scherer R, Fraccalvieri D, Frago R, Kreisler E

Publicada: 1 dic 2017
Resumen:
The implantation of Gatekeeper (TM) (GK) represents a new option for the treatment of fecal incontinence (FI). The aim of this study was to analyze the postoperative morbidity associated with GK and to determine its clinical efficacy after at least 1 year of follow-up. This was a multicenter, retrospective and longitudinal study of patients with FI who were treated with GK at our institutions between January 2010 and December 2015. Patients with FI without sphincter lesions or with sphincter injuries < 120A degrees and with low anterior resection syndrome were included. Postoperative complications, long-term adverse effects and migration were recorded. FI severity was assessed using the Vaizey score. Patients were classified as responders or non-responders according to the improvement of the Vaizey score (aeA than 50 and < 50%, respectively) during the first 6 months after implantation. Forty-nine consecutive patients treated with GK between 2010 and 2015 were included (11 males and 38 females, mean age 63.3 years, SD 13.5). No postoperative and long-term complications were observed. Prosthesis migration was observed in 51% of patients. Twenty-three patients (48%) were classified as responders and 25 (52%) as non-responders. The mean Vaizey score at baseline, 6, 12 months and last visit post-surgery in the responder group was, respectively, 13.3 (SD 3.8), 4.3 (SD 2.1), 4.2 (SD 3.6) and 5.7 (SD 5.3). Significant differences were observed between the mean baseline Vaizey score and the mean 6, 12 and last follow-up Vaizey score values (p < 0.001). In long-term follow-up (2.7 years (SD 1.1)), responders maintained an improvement of more than 50% of the baseline Vaizey score. In the non-responder group the mean number of migrated prostheses was higher than in the responder group (2.4 SD 2.5 vs. 1.0 SD 1.6; p = 0.040). GK is a safe and effective procedure in more than 50% of the patients for at least 1 year after the implantation.

Filiaciones:
Trenti L:
 Colorectal Unit, Department of General and Digestive Surgery, Bellvitge University Hospital, University of Barcelona, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain

 Bellvitge Biomedical Investigation Institute, Barcelona, Spain

Biondo S:
 Colorectal Unit, Department of General and Digestive Surgery, Bellvitge University Hospital, University of Barcelona, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

 Bellvitge Biomedical Investigation Institute, Barcelona, Spain.

Noguerales F:
 Department of General and Digestive Surgery, University Hospital Principe de Asturias, University of Alcalá, Alcalá de Henares, Madrid, Spain

Nomdedeu J:
 Department of Gastrointestinal Surgery, Consorcio Hospitalario Provincial de Castellón de la Plana, Castellón de la Plana, Castellón, Spain

Coret A:
 Department of Gastrointestinal Surgery, Consorcio Hospitalario Provincial de Castellón de la Plana, Castellón de la Plana, Castellón, Spain

Scherer R:
 Center of Colorectal and Pelvic Floor Surgery, Waldfriede Hospital, Berlin, Germany

Fraccalvieri D:
 Colorectal Unit, Department of General and Digestive Surgery, Bellvitge University Hospital, University of Barcelona, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain

 Bellvitge Biomedical Investigation Institute, Barcelona, Spain

Frago R:
 Colorectal Unit, Department of General and Digestive Surgery, Bellvitge University Hospital, University of Barcelona, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain

 Bellvitge Biomedical Investigation Institute, Barcelona, Spain

Kreisler E:
 Colorectal Unit, Department of General and Digestive Surgery, Bellvitge University Hospital, University of Barcelona, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain

 Bellvitge Biomedical Investigation Institute, Barcelona, Spain
ISSN: 11236337





Techniques In Coloproctology
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 21 Número: 12
Páginas: 963-970
WOS Id: 000417294500007
ID de PubMed: 29159781

MÉTRICAS